Paul Limburg

Chief Medical Officer for Screening

Exact Sciences

Dr. Limburg holds the academic rank of Professor of Medicine in the Mayo Clinic College of Medicine and serves as Chief Medical Officer for Screening at Exact Sciences. His previous Mayo Clinic leadership roles include Co-Leader of the Cancer Prevention and Control Program, Medical Director for Global Business Solutions, Medical Director for the Office of Health & Well-Being, Physician Lead for Prediction & Prevention in the Center for Innovation, and Research Director for the Healthy Living Program, among others.  Dr. Limburg has served on several enterprise-wide committees at Mayo Clinic, including the Management Team and the Clinical Practice Committee. 

With respect to his research activities, Dr. Limburg is Principal Investigator for the Cancer Prevention Network, an international, multicenter clinical trial consortium funded by the U. S. National Cancer Institute since 23. He is a Fellow in the American Gastroenterological Association, an inductee into the honorary American Society for Clinical Investigation, and a member of the Sigma Xi scientific research honor society. His primary research interests include screening innovation, cancer chemoprevention, and molecular epidemiology. To date, Dr. Limburg has published over 14 peer-reviewed articles and 19 book chapters.   

Dr. Limburg earned his BA degree in chemistry from Augustana College (Sioux Falls, SD), MD degree from Mayo Medical School, and MPH degree from the Johns Hopkins School of Hygiene and Public Health. He completed his Internal Medicine residency and Gastroenterology & Hepatology fellowship training at the Mayo Graduate School of Medicine. Dr. Limburg also completed an advanced fellowship in Preventive Oncology at the U. S. National Cancer Institute.

Dr. Limburg has received numerous awards and honors throughout his career, including a Cancer Prevention Laurel for Dedication to Community Programs from the Cancer Research and Prevention Foundation of America, a Career Development Award from the National Cancer Institute, and the Karis Award from Mayo Clinic. Dr. Limburg was selected to serve as Chair for the 213 Frontiers in Cancer Prevention Research Program Committee (American Association for Cancer Research) and is widely recognized for his clinical, research, and leadership contributions in the field of cancer prevention.